These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34552061)

  • 1. MiR-9-3p regulates the biological functions and drug resistance of gemcitabine-treated breast cancer cells and affects tumor growth through targeting MTDH.
    Wang Y; Dong L; Wan F; Chen F; Liu D; Chen D; Long J
    Cell Death Dis; 2021 Sep; 12(10):861. PubMed ID: 34552061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis.
    Liu Y; Wei G; Ma Q; Han Y
    Thorac Cancer; 2020 Feb; 11(2):394-407. PubMed ID: 31901156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells.
    Hu W; Liu Q; Pan J; Sui Z
    Biomed Pharmacother; 2018 Sep; 105():887-898. PubMed ID: 30021382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-125a-3p is responsible for chemosensitivity in PDAC by inhibiting epithelial-mesenchymal transition via Fyn.
    Liu G; Ji L; Ke M; Ou Z; Tang N; Li Y
    Biomed Pharmacother; 2018 Oct; 106():523-531. PubMed ID: 29990840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).
    Wan S; Liu Z; Chen Y; Mai Z; Jiang M; Di Q; Sun B
    Bioengineered; 2021 Dec; 12(2):11959-11977. PubMed ID: 34818974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microRNA-141-3p/ CDK8 pathway regulates the chemosensitivity of breast cancer cells to trastuzumab.
    Song W; Wu S; Wu Q; Zhou L; Yu L; Zhu B; Gong X
    J Cell Biochem; 2019 Aug; 120(8):14095-14106. PubMed ID: 31087707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210.
    Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T
    Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced miR-363-3p expression in non-small cell lung cancer is associated with gemcitabine resistance via targeting of CUL4A.
    Bian WG; Zhou XN; Song S; Chen HT; Shen Y; Chen P
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):649-659. PubMed ID: 30720173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Wang D; Zheng Y
    Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of circ_0006528 Suppresses Cell Proliferation, Migration, Invasion, and Adriamycin Chemoresistance via Regulating the miR-1236-3p/CHD4 Axis in Breast Cancer.
    Hao J; Du X; Lv F; Shi Q
    J Surg Res; 2021 Apr; 260():104-115. PubMed ID: 33333383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression.
    Yang Y; Zhang G; Li J; Gong R; Wang Y; Qin Y; Ping Q; Hu L
    Pathol Res Pract; 2021 Dec; 228():153676. PubMed ID: 34753061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
    Shi Y; Yan F; Wang F; Pan L
    Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-942 regulates the function of breast cancer cell by targeting FOXA2.
    Zhang J; Zhang Z; Sun J; Ma Q; Zhao W; Chen X; Qiao H
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31701999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.
    Chen Z; Ma Y; Pan Y; Zhu H; Yu C; Sun C
    Mol Cell Probes; 2018 Aug; 40():19-26. PubMed ID: 29908229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.
    Liu Y; Li Y; Wang R; Qin S; Liu J; Su F; Yang Y; Zhao F; Wang Z; Wu Q
    J Exp Clin Cancer Res; 2016 Jan; 35():19. PubMed ID: 26817584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-216a-3p regulates the proliferation, apoptosis, migration, and invasion of lung cancer cells via targeting COPB2.
    Wang X; Shi J; Niu Z; Wang J; Zhang W
    Biosci Biotechnol Biochem; 2020 Oct; 84(10):2014-2027. PubMed ID: 32619135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI
    Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR-140-3p/SKA2 axis.
    Dou D; Ren X; Han M; Xu X; Ge X; Gu Y; Wang X; Zhao S
    Mol Oncol; 2021 Feb; 15(2):697-709. PubMed ID: 33244865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.